A dose-response study of felodipine in patients remaining hypertensive on a beta blocker. Canadian Felodipine Study Group.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D015736:Felodipine; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D009568:Nitrendipine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011897:Random Allocation
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D009568:Nitrendipine; D015736:Felodipine